Skip to main content
  • Home
  • About
  • Faculty Experts
  • For The Media
  • Videos
  • Topics
    • Alumni
    • Events
    • Faculty
    • Library
    • Research
    • Students
    • All Topics
  • Contact
  • Submit
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
Sections
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
  • Home
  • About
  • Faculty Experts
  • For The Media
  • Videos
  • Topics
    • Alumni
    • Events
    • Faculty
    • Library
    • Research
    • Students
    • All Topics
  • Contact
  • Submit

Chemist to Study ‘Orally Effective Therapy’ to Fight Obesity

Wednesday, August 14, 2013, By Rob Enslin
Share
National Institutes of Healthresearch

Robert Doyle will experiment with ‘gut hormone’ and vitamin B12

A rendering of the Vitamin B12 and PYY3-36 conjugate (Illustration by Damian Allis)

A rendering of the Vitamin B12 and PYY3-36 conjugate (Illustration by Damian Allis)

A chemist in The College of Arts and Sciences has received a federal grant to study the oral administration of PYY3-36, a peptide that inhibits food intake by naturally switching off one’s appetite. The project is said to have major implications for people struggling with obesity and associated diseases, such as cardiovascular disease and diabetes.

Robert Doyle, associate professor of chemistry, has been awarded $221,000 by the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. His project will last for two years, with the option of a third, and will involve Christian L. Roth, a pediatric endocrinologist at Seattle Children’s Hospital.

The award comes on the heels of a landmark decision by the American Medical Association to categorize obesity as a disease requiring a “range of interventions,” including weight-loss counseling, medication and surgery.

“Obesity is one of today’s leading health challenges—not only in North America and Europe, but also in Asia and Australia,” says Doyle, whose expertise spans chemistry and biology. “The prevalence of obesity among children and adolescents is of particular concern, despite public health education and initiatives.”

At the heart of Doyle’s project is PYY3-36, a gut hormone that presumably supports the long-term benefits of bariatric surgery—currently, the only effective long-term exogenous treatment for obesity.

Doyle plans to utilize vitamin B12, which supports functioning of the brain and nervous system, to help protect and carry PYY3-36 through the gastrointestinal tract.

“We will trick the digestive system into carrying our peptide [PYY3-36], along with the B12,” says Doyle, who also holds faculty appointments in biology and biochemistry. “PYY3-36 will then send messages between the intestine and the brain, as well as in the brain, itself, telling you when you’re full. That’s why it’s called the ‘satiety peptide.’”

Since pharmacotherapy is merely an adjunct treatment for obesity management, the race is on to develop novel anti-obesity drugs that are safe and effective.

Doyle believes that orally effective therapy—particularly involving PYY3-36’s appetite-suppressing properties—may be the way forward.

“Ultimately, we want to develop an oral formulation that takes advantage of our bodies’ own appetite-control elements,” he says. “But first, we need to study its effects.”

Doyle, who earned a Ph.D. from Trinity College in Dublin, joined SU’s faculty in 2005. Since then, he has produced award-winning research that may lead to new treatments and diagnostic tools for diabetes and cancer. Much of his work, such as the utilization of B12 to orally deliver proteins, draws on chemical or systems biology research.

  • Author

Rob Enslin

  • Recent
  • Dining Centers to Resume In-Person Dining Monday, April 19, at 11 a.m.
    Sunday, April 18, 2021, By News Staff
  • Libraries Receive Two Access and Digitization Grants
    Sunday, April 18, 2021, By Cristina Hatem
  • Pre-Registration Open for On-Campus Vaccine Clinic
    Friday, April 16, 2021, By News Staff
  • Commencement 2021 Update
    Friday, April 16, 2021, By News Staff
  • Activities for the Weekend of April 15-19 | Submit Proof of Vaccination
    Thursday, April 15, 2021, By News Staff

More In Uncategorized

Syracuse Views Spring 2021

We want to know how you experience Syracuse University. Take a photo and share it with us. We select photos from a variety of sources. Submit photos of your University experience using #SyracuseU on social media, fill out a submission…

“Why aren’t NY farm workers in the Covid-19 vaccine line?”

Laura-Anne Minkoff-Zern, associate professor of food studies in Falk College, was interviewed for the Syracuse.com story “Why aren’t NY farm workers in the Covid-19 vaccine line?” Minkoff-Zern, an expert on the intersections of food and social justice, comments on the…

“Biden to broaden US-Mexican relations, keep immigration at top.”

Gladys McCormick, associate professor of history in the Maxwell School, was quoted in the Al Jazeera story “Biden to broaden US-Mexican relations, keep immigration at top.” McCormick, an expert on US-Mexico relations, believes that Mexican president Andres Manuel Lopez Obrador…

“The long game: COVID changed the way we play, watch, cheer”

Dennis Deninger, professor of practice in Falk College and the Newhouse School, was quoted in the Associated Press story “The long game: COVID changed the way we play, watch, cheer.” Deninger, an expert on sports television and media, believes that…

“Meghan Markle and Prince Harry Ratings: Oprah Interview Draws 17.1 Million Viewers.”

Robert Thompson, Trustee Professor of television, radio and film and director of the Bleier Center for Television and Popular Culture in the Newhouse School, was quoted in The Wall Street Journal story “Meghan Markle and Prince Harry Ratings: Oprah Interview…

Subscribe to SU Today

If you need help with your subscription, contact sunews@syr.edu.

Connect With Us

  • Twitter
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
Social Media Directory

For the Media

Find an Expert Follow @SyracuseUNews
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • @SyracuseU
  • @SyracuseUNews
  • @SUCampus
  • Social Media Directory
  • Accessibility
  • Privacy
  • Campus Status
  • Syracuse.edu
© 2021 Syracuse University News. All Rights Reserved.